If we can develop the Covid vaccine so quickly, imagine the implications that has for other global challenges.
Show Notes
The Covid-19 vaccine was developed at an unusually rapid pace, and now the public's expectations are high for what science can deliver. It's a good thing we're in a science moment. Gobs of data are being produced, researchers are collaborating more, and the public is engaged. But is the pace of discovery keeping up with the science? Alison Snyder, managing editor at Axios, interviews Darío Gil, senior vice president and director of IBM Research at IBM, Serpil Erzurum, chief research and academic officer of Cleveland Clinic, and Nicholas Dirks, president and CEO of the New York Academy of Sciences, about the pace of discovery in an age of streamlined research and development processes and advanced computing.
Explore
Related episodes
As scientists work to develop a vaccine to battle the coronavirus pandemic, many people question whether the process has been rushed and if the results will be effective and safe. The U.S. Food and Drug Administration is responsible for approving new vaccines in this country. FDA commissioner Dr. Stephen Hahn and former FDA commissioner Dr. Peggy Hamburg say the agency use...
Antibodies, convalescent plasma, gene-based vaccines — you may have heard these terms on the evening news, but what do they mean? How might they help in the battle against Covid-19?
David Agus, author of "The Lucky Years," says we’re living in a golden age when the latest science and technology can customize care.
